| Literature DB >> 8100916 |
H Tamashiro1, W Maskill, J Emmanuel, A Fauquex, P Sato, D Heymann.
Abstract
Available tests to detect antibody to human immunodeficiency virus (HIV) have a range of applications, and injudicious selection and inappropriate use can add a significant financial burden to budgets for AIDS programmes in developing countries. There are several ways by which the cost of HIV antibody testing can be reduced; they include use of tests appropriate for existing laboratory capabilities; adoption of cost-effective testing strategies; pooling of serum samples before testing; and ensuring best possible purchase prices. Each approach can significantly reduce the cost of HIV antibody testing alone or in combination, which increases the potential sustainability of antibody testing programmes, even in settings of limited resources.Entities:
Keywords: Acquired Immunodeficiency Syndrome; Antibodies; Biology; Commerce; Cost Effectiveness; Developing Countries; Diseases; Economic Factors; Evaluation; Evaluation Indexes; Examinations And Diagnoses; Hiv Infections; Hiv Serodiagnosis; Immunity; Immunologic Factors; Laboratory Examinations And Diagnoses; Laboratory Procedures; Macroeconomic Factors; Physiology; Prices; Quantitative Evaluation; Viral Diseases
Mesh:
Substances:
Year: 1993 PMID: 8100916 DOI: 10.1016/0140-6736(93)91289-x
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321